BIT
AVXL icon

BlackRock Institutional Trust’s Anavex Life Sciences AVXL Stock Holding History

BlackRock Institutional Trust’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.13M Hold
284,540
– – ﹤0.01% 3258
2016
Q3 		$1.03M Hold
284,540
– – ﹤0.01% 3283
2016
Q2 		$1.74M Buy
+284,540
New +$1.37M ﹤0.01% 3087

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock Institutional Trust's AVXL Position: Q4 2016 in Review

BlackRock Institutional Trust held its Anavex Life Sciences (AVXL) position steady in Q4 2016 at 284,540 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3258.

BlackRock Institutional Trust first reported a position in AVXL in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.74M in Q2 2016. 59 funds tracked by Wall St. Rank hold AVXL as of Q4 2016.

  • BlackRock Institutional Trust held 284,540 shares of Anavex Life Sciences worth $1.13M as of Q4 2016.
  • BlackRock Institutional Trust left its Anavex Life Sciences share count unchanged in Q4 2016.
  • Anavex Life Sciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3258 holding.
  • BlackRock Institutional Trust first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Institutional Trust's Anavex Life Sciences position peaked at $1.74M in Q2 2016.
  • 59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.